PROTALIX BIOTHERAPEUTICS, INC. (PLX)

[Kronberg]

I want to add my two cents. In addition to this stupid statement about the need for financing, the market had information about the departure of the two main people of the company. All this in my opinion and has dropped the share price so much. The money doesn’t end tomorrow. They had to work on this problem and declare after solving it. I don’t think they needed to be safe themselves. Before taking their positions all aspects related to the company and the financial situation of corse were discussed in detail with the board of directors etc. My imagination was enough only for the following. This is a signal to a potential buyer that Protalix is for sale and inexpensive. Although if the following statement "The data to date, from our product for Fabry has been fantastic. We clearly have a drug candidate with the potential to be much better than the current standard of care." is true, I think Chiesi easy can pay $200 - 300 million not for the whole company but for the full right to PRX-102, let's say at the and of this year. This money would be enough for the successful development of the remaining two candidates and pipeline. They have many opportunities to solve financing problems. Why this statement was needed is a big mystery. Any ideas?